Free Trial

Sanara MedTech (SMTI) Competitors

Sanara MedTech logo
$25.84 +0.19 (+0.74%)
As of 10:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SMTI vs. MDXG, INMD, SSII, KMTS, IRMD, SIBN, SMLR, EMBC, CBLL, and BVS

Should you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

Sanara MedTech vs. Its Competitors

Sanara MedTech (NASDAQ:SMTI) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

MiMedx Group has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$86.67M2.65-$9.66M-$1.34-19.28
MiMedx Group$348.88M2.83$42.42M$0.2724.80

Sanara MedTech currently has a consensus target price of $49.50, indicating a potential upside of 91.56%. MiMedx Group has a consensus target price of $11.50, indicating a potential upside of 71.77%. Given Sanara MedTech's higher probable upside, equities analysts plainly believe Sanara MedTech is more favorable than MiMedx Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

MiMedx Group has a net margin of 11.40% compared to Sanara MedTech's net margin of -12.48%. MiMedx Group's return on equity of 22.70% beat Sanara MedTech's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanara MedTech-12.48% -29.22% -13.20%
MiMedx Group 11.40%22.70%16.77%

In the previous week, MiMedx Group had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for MiMedx Group and 1 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.94 beat MiMedx Group's score of 0.37 indicating that Sanara MedTech is being referred to more favorably in the media.

Company Overall Sentiment
Sanara MedTech Positive
MiMedx Group Neutral

Sanara MedTech has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500.

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by insiders. Comparatively, 1.7% of MiMedx Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

MiMedx Group beats Sanara MedTech on 11 of the 14 factors compared between the two stocks.

Get Sanara MedTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMTI vs. The Competition

MetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$229.72M$10.38B$5.71B$9.50B
Dividend YieldN/A2.00%4.60%3.99%
P/E Ratio-19.2816.9627.8819.97
Price / Sales2.6526.86452.35101.58
Price / CashN/A23.2136.5558.97
Price / Book5.813.648.635.89
Net Income-$9.66M$234.77M$3.24B$258.50M
7 Day Performance-1.79%5.23%3.90%2.07%
1 Month Performance-7.94%7.15%10.47%12.39%
1 Year Performance-19.73%-14.37%34.29%19.25%

Sanara MedTech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMTI
Sanara MedTech
1.6853 of 5 stars
$25.84
+0.7%
$49.50
+91.6%
-17.8%$229.72M$86.67M-19.2860Positive News
MDXG
MiMedx Group
3.4359 of 5 stars
$6.80
+2.1%
$12.50
+83.8%
-7.2%$1.00B$348.88M25.19870Upcoming Earnings
INMD
InMode
3.7863 of 5 stars
$14.74
+0.2%
$18.54
+25.8%
-17.9%$931.70M$392.41M6.33480Upcoming Earnings
SSII
SS Innovations International
N/A$4.75
-4.8%
N/AN/A$919.60M$20.65M0.004Gap Down
KMTS
Kestra Medical Technologies
N/A$15.43
+3.5%
$27.50
+78.2%
N/A$792.32M$52.64M0.00300
IRMD
iRadimed
4.9269 of 5 stars
$58.07
+0.9%
$72.00
+24.0%
+18.0%$738.65M$73.24M37.46110Positive News
Upcoming Earnings
Gap Down
SIBN
SiBone
4.0725 of 5 stars
$17.32
+0.7%
$22.50
+29.9%
+5.7%$738.18M$167.18M-27.06350News Coverage
SMLR
Semler Scientific
2.6432 of 5 stars
$45.23
-0.7%
$89.00
+96.8%
+18.1%$619.20M$56.29M-17.33120
EMBC
Embecta
4.6843 of 5 stars
$10.37
-1.0%
$19.33
+86.4%
-30.4%$606.05M$1.08B11.522,100
CBLL
CeriBell
2.3806 of 5 stars
$16.38
+1.5%
$32.14
+96.2%
N/A$591.97M$65.44M0.00N/A
BVS
Bioventus
3.3652 of 5 stars
$6.81
-2.3%
$13.75
+101.9%
-14.2%$559.40M$567.70M-11.161,200

Related Companies and Tools


This page (NASDAQ:SMTI) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners